Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01994993 · ClinicalTrials.gov registry record · Phase 2
Antibiotic Safety (SCAMP)
A Phase 2 study, sponsored by Michael Cohen-Wolkowiez.
- Completed
- Registry status
- Phase 2
- Development phase
- 260
- Enrollment target
NCT01994993 is a Phase 2 study that has completed, run by Michael Cohen-Wolkowiez. The registered enrollment target is 260 participants.
The verdict
NCT01994993, a Phase 2 study, has completed, sponsored by Michael Cohen-Wolkowiez.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 260 participants
- Enrollment target
Study Summary
The main purpose of this study is evaluate whether it is safe or not to use various combination of antibiotics (ampicillin, metronidazole, clindamycin, piperacillin-tazobactam, gentamicin) in treating infants with complicated intra-abdominal infections
Interventions
- DRUG ampicillin and metronidazole and gentamicin
- DRUG ampicillin and gentamicin and clindamycin
- DRUG gentamicin and Piperacillin- tazobactam
- DRUG standard of care antibiotics and metronidazole
- DRUG metronidazole, clindamycin, or piperacillin-tazobactam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2013-12 |
| Est. Completion | 2017-04-20 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01994993
The ClinicalTrials.gov registry entry for NCT01994993 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 260 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michael Cohen-Wolkowiez, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which ampicillin and metronidazole and gentamicin is the first listed.
NCT01994993 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01994993 about?
NCT01994993 is a clinical study titled "Antibiotic Safety (SCAMP)". The main purpose of this study is evaluate whether it is safe or not to use various combination of antibiotics (ampicillin, metronidazole, clindamycin, piperacillin-tazobactam, gentamicin) in treating infants with complicated intra-abdominal infections
What is the current status of trial NCT01994993?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 260 participants. The study started on 2013-12. Estimated completion is 2017-04-20.
What interventions are being tested in trial NCT01994993?
The interventions under investigation include: ampicillin and metronidazole and gentamicin (DRUG), ampicillin and gentamicin and clindamycin (DRUG), gentamicin and Piperacillin- tazobactam (DRUG), standard of care antibiotics and metronidazole (DRUG), metronidazole, clindamycin, or piperacillin-tazobactam (DRUG).
Who is sponsoring clinical trial NCT01994993?
This trial is sponsored by Michael Cohen-Wolkowiez, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.